BCWM
EBS icon

Bartlett & Co Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Bartlett & Co Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,000
Closed -$14.7K – 1185
2023
Q2 		$14.7K Hold
2,000
– – ﹤0.01% 866
2023
Q1 		$20.7K Hold
2,000
– – ﹤0.01% 705
2022
Q4 		$23.6K Hold
2,000
– – ﹤0.01% 693
2022
Q3 		$42K Sell
2,000
-350
-15% -$9.74K ﹤0.01% 590
2022
Q2 		$72.9K Hold
2,350
– – ﹤0.01% 514
2022
Q1 		$96.5K Buy
+2,350
New +$104K ﹤0.01% 492

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bartlett & Co Wealth Management's EBS Position: Q3 2023 in Review

Bartlett & Co Wealth Management sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 2,000 shares — an estimated $14.7K sold.

Bartlett & Co Wealth Management first reported a position in EBS in Q1 2022 and held it in 6 quarters. The position peaked at $96.5K in Q1 2022. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • Bartlett & Co Wealth Management reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 2,000 Emergent Biosolutions shares in Q3 2023, an estimated $14.7K.
  • Bartlett & Co Wealth Management first reported a position in Emergent Biosolutions in Q1 2022 and held it in 6 quarters.
  • Bartlett & Co Wealth Management's Emergent Biosolutions position peaked at $96.5K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2023, filed 14 Feb 2024.